Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

(RTTNews) - Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the deal, Daiichi Sankyo will acquire world-wide rights ...

Crystal Palace are investigating allegations of racist abuse by supporters towards midfielder Daichi Kamada after he was sent off against Fulham on Saturday. The Japan midfielder received a red ...

Want to keep track of all the upcoming Xbox Series X games out there? Well, the good news is that while we're almost at the end of a bumper year for the Microsoft console, there are still plenty ...

Despite being a volleyball anime, Haikyuu!! attracts a global fanbase consisting of ... Shonen Jump began in February 2012 with 42 collected tankōbon volumes released. Hinata Shoyo is a highly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Gerdau S/A Ord-3.61% R$39.94B ...

Crystal Palace are investigating allegations of racist abuse by supporters towards midfielder Daichi Kamada after he was sent off against Fulham on Saturday. The summer signing – who scored the ...

8316.T Sumitomo Mitsui Financial Group, Inc.

Jinhuei Enya Dai is a practitioner and researcher who believes that pedagogy is theory in practice, and has dedicated herself to innovative pedagogy, an ecological perspective, content-based ...